Aug
30
A patch containing testosterone has been developed to boost
women’s sex drive.
The patch, developed by Proctor and Gamble, is designed for
women facing an early menopause.
Known as
href =”http://www.firstmed.co.uk”> intrinsa,
the product is a thin, clear patch worn on the abdomen and applied twice a
week. The treatment is delivered using the patch, which constantly releases
small amounts of testosterone that is absorbed through your skin into the
bloodstream.
The testosterone in Intrinsa is the same hormone as that
produced naturally in men and women. Testosterone is a key mediator of sexual
desire in women.
Decreases in testosterone levels in women have been
associated with low sexual desire, reduced sexual arousal and reduced sexual
thoughts. All of these problems can cause personal distress or relationship
difficulties. By introducing testosterone through an Intrinsa patch, increased
levels of testosterone can lead to a normalisation of sexual desire.
The application of Intrinsa will not have an immediate
effect. It may take up to one month before there is a noticeable improvement.
If there has been no positive effect from using Intrinsa within 3 to 6 months,
use of the product should be discontinued
Each patch contains 8.4 mg of testosterone, releasing 300
micrograms over a 24 hour period is available on prescription. The Intrinsa
patch must be changed every 3 to 4 days
The new medicine became available after trials involving
over 500 women who had had hysterectomies found the patch led to a 74 per cent
increase in satisfying sex.
Nick Panay, consultant gynaeco
logist and patron of The
Daisy Network, a nationwide support group for women with premature menopause,
said: “Intrinsa offers real medical hope to these women as studies showed
that the patch increases sexual desire and satisfying sexual activity, while
reducing associated distress.”
Medical surveys reveal that approximately 43% of all adult
women suffer from what specialists consider various forms of sexual
dysfunction. Although not even nearly publicized as male erectile dysfunction,
female sexual dysfunction is just as serious and commonly met.
The definition given by specialists to female sexual
dysfunction (FSD) is the consistent or inconsistent lack of sexual fantasies,
desire and/or initiative in order to perform sexual intercourse, fact which
leads to a state of personal distress or difficult interpersonal relationships.
Female sexual dysfunction is also called hypoactive sexual desire disorder
(HSSD) and is very prominent in cases of early menopause.
Around a million women in the UK have had an early
menopause due to surgery to remove their ovaries during a hysterectomy,
according to Procter and Gamble
This information has been brought to you by Firstmed.co.uk,
the UK’s leading online pharmacy specialising in the treatment sex related
problems, including ED and low sex drive. If you wish to discuss any of the above
issues in more detail, do not hesitate to contact info@firstmed.co.ukor call +44
(0)870 199 5287
Comments
Leave a Reply